Form 4 Filing: Nachman Shlomo Acquires AtriCure, Inc. Common Stock

On May 18, 2026, Nachman Shlomo acquired 6,144 shares of AtriCure, Inc. Common Stock through a Restricted Stock Award under the company's 2023 Stock Incentive Plan. These shares are subject to a one-year vesting period from the grant date. Following this transaction, Mr. Shlomo directly owns 24,655 shares of the company's common stock. The transaction was reported on Form 4, filed on May 20, 2026. Mr. Shlomo is a director at AtriCure, Inc.